We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Zotefoams Plc | LSE:ZTF | London | Ordinary Share | GB0009896605 | ORD 5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
7.00 | 1.65% | 432.00 | 426.00 | 440.00 | 440.00 | 426.00 | 440.00 | 29,349 | 16:35:12 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Plastics Foam Products | 126.98M | 9.24M | 0.1892 | 22.52 | 208.08M |
TIDMZTF
RNS Number : 7986M
Zotefoams PLC
25 May 2022
Zotefoams plc
('the Company')
Result of the 2022 Annual General Meeting
25 May 2022 - The Company announces that at its Annual General Meeting held on 25 May 2022 at its offices at 675 Mitcham Road, Croydon CR9 3AL, all of the resolutions tabled at the meeting were passed on a poll vote. Resolutions 1 to 13 inclusive were passed as ordinary resolutions and resolutions 14 to 17 inclusive were passed as special resolutions.
The total number of ordinary shares in issue in relation to the AGM is 48,621,234. Votes were cast by shareholders in respect of 30,901,851 ordinary shares amounting to 63.5% of the issued share capital.
The votes cast* were recorded as follows:
Resolution For % of Against % of Votes votes votes Withheld cast cast To receive the Annual Report of the Company for the year 1. ended 31 December 2021 30,901,851 100 0 0 123 ---------------------------------- ----------- ------- ---------- ------- ---------- To approve the Annual Statement by the Chair of the Remuneration Committee and the Annual Report on Remuneration for the year ended 31 December 2021 set out on pages 88 to 99 of the 2. Annual Report. 30,766,637 99.6 123,706 0.40 11,631 ---------------------------------- ----------- ------- ---------- ------- ---------- To declare a final dividend for the year ended 31 December 2021 of 4.40 pence per ordinary share, such dividend to be payable on 1 June 2022 to shareholders on the register of members of the Company at the close of business on 3. 6 May 2022. 30,901,851 100 0 0 123 ---------------------------------- ----------- ------- ---------- ------- ---------- To re-elect S P Good as a 4. Director. 28,713,535 92.92 2,187,376 7.08 1,063 ---------------------------------- ----------- ------- ---------- ------- ---------- To re-elect D B Stirling as 5. a Director. 30,891,727 99.97 9,184 0.03 1,063 ---------------------------------- ----------- ------- ---------- ------- ---------- T o re-elect G C McGrath as 6. a Director. 30,891,594 99.97 9,317 0.03 1,063 ---------------------------------- ----------- ------- ---------- ------- ---------- T o re-elect J D Carling as 7. a Director. 30,768,067 99.57 132,844 0.43 1,063 ---------------------------------- ----------- ------- ---------- ------- ---------- T o re-elect A M Fielding 8. as a Director. 30,657,251 99.60 123,660 0.40 121,063 ---------------------------------- ----------- ------- ---------- ------- ---------- To re-elect D G Robertson 9. as a Director. 30,768,067 99.57 132,844 0.43 1,063 ---------------------------------- ----------- ------- ---------- ------- ---------- To re-elect C A Wall as a 10. Director. 30,777,251 99.60 123,660 0.40 1,063 ---------------------------------- ----------- ------- ---------- ------- ---------- To re-appoint PKF Littlejohn 11. LLP as Auditor of the Company. 30,760,355 99.93 20,556 0.07 121,063 ---------------------------------- ----------- ------- ---------- ------- ---------- To authorise the Audit Committee to determine the Auditor's 12. remuneration. 30,868,035 99.93 20,556 0.07 13,383 ---------------------------------- ----------- ------- ---------- ------- ---------- To authorise the Directors 13. to allot shares. 30,752,773 99.55 138,954 0.45 10,247 ---------------------------------- ----------- ------- ---------- ------- ---------- To authorise the Directors to allot equity securities 14. for cash. 30,771,577 99.61 120,150 0.39 10,247 ---------------------------------- ----------- ------- ---------- ------- ---------- To authorise the Directors, in addition to resolution 14, to allot further equity securities for financing (and 15. refinancing) purposes only. 30,768,441 99.61 120,150 0.39 13,383 ---------------------------------- ----------- ------- ---------- ------- ---------- To authorise market purchases 16. of shares. 30,891,468 100 1,199 0 9,307 ---------------------------------- ----------- ------- ---------- ------- ---------- That a general meeting other than an annual general meeting may be called on not less 17. than 14 clear days' notice. 30,118,029 97.50 773,698 2.50 10,247 ---------------------------------- ----------- ------- ---------- ------- ----------
* Total votes cast excludes votes withheld as a vote withheld is not a vote in law.
Further details of the resolutions (including the text of the resolutions) are given in the Notice of the 2022 Annual General Meeting, which is on page 156 of the 2021 Annual Report and which is also available on the Company's website.
Pursuant to Listing Rule 9.6, the Company also confirms that a copy of all relevant resolutions passed at its AGM will shortly be made available for public inspection via the National Storage Mechanism.
Lydia Harratt
Group Company Secretary
Zotefoams plc
020 8664 1600
About Zotefoams plc
Zotefoams plc (LSE - ZTF) is a world leader in cellular materials technology delivering optimal material solutions for the benefit of society. Utilising a variety of unique manufacturing processes, including environmentally friendly nitrogen expansion for lightweight AZOTE(R) polyolefin and ZOTEK(R) high-performance foams, Zotefoams sells to diverse markets worldwide. Zotefoams uses its own cellular materials to manufacture T-FIT(R) advanced insulation for demanding industrial markets. Zotefoams also owns and licenses patented microcellular foam technology to reduce plastic use in extrusion applications and for ReZorce(R) mono-material recyclable barrier packaging.
Zotefoams is headquartered in Croydon, UK, with additional manufacturing sites in Kentucky, USA and Brzeg, Poland (foam manufacture), Oklahoma, USA (foam products manufacture and conversion), Massachusetts, USA (MuCell Extrusion) and Jiangsu Province, China (T-FIT).
www.zotefoams.com
AZOTE(R) , ZOTEK(R) , ReZorce(R) and T-FIT(R) are registered trademarks of Zotefoams plc.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
RAGFLFIFEIIEFIF
(END) Dow Jones Newswires
May 25, 2022 08:04 ET (12:04 GMT)
1 Year Zotefoams Chart |
1 Month Zotefoams Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions